基本信息
views: 378
Career Trajectory
Bio
Clinical Expertise
Leukemias; New Drug Development
He has identified cell signaling components critical to the growth of cancer cells in chronic myeloid leukemia, prostate and other cancers, resulting in the development of multiple FDA-approved inhibitors in clinical use today.
Leukemias; New Drug Development
He has identified cell signaling components critical to the growth of cancer cells in chronic myeloid leukemia, prostate and other cancers, resulting in the development of multiple FDA-approved inhibitors in clinical use today.
Research Interests
Papers共 573 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Samir Zaidi, Jooyoung Park,Joseph M Chan,Martine P Roudier,Jimmy L Zhao,Anuradha Gopalan,Kristine M Wadosky,Radhika A Patel,Erolcan Sayar,Wouter R Karthaus, D Henry Kates,Ojasvi Chaudhary,
Proceedings of the National Academy of Sciences of the United States of Americano. 28 (2024): e2322203121-e2322203121
NPJ precision oncologyno. 1 (2024): 104-104
Cancer Researchno. 6_Supplement (2024): 1246-1246
Srushti Kittane,Erik Ladewig,Taibo Li,Jillian Love,Amaia Arruabarrena-Aristorena, Xinyu Guo,Mirna Sallaku,Liliana Garcia-Martinez,Ryan Blawski, Javier Carmona Sanz, Christopher Simpkins,Wanlu Chen,
Cancer Researchno. 6_Supplement (2024): 1245-1245
Urologic Oncology: Seminars and Original Investigations (2024)
biorxiv(2024)
Molecular oncologyno. 2 (2024): 245-279
Cancer Researchno. 6_Supplement (2024): 2004-2004
Rodrigo Romero,Tinyi Chu,Tania J González-Robles,Perianne Smith,Yubin Xie, Harmanpreet Kaur, Sara Yoder,Huiyong Zhao, Chenyi Mao,Wenfei Kang, Maria V Pulina,Kayla E Lawrence,
bioRxiv : the preprint server for biology (2024)
Load More
Author Statistics
#Papers: 579
#Citation: 115373
H-Index: 134
G-Index: 339
Sociability: 8
Diversity: 3
Activity: 158
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn